New AI capabilities will help scientists identify, optimize, and validate new molecules. Additional applications include manufacturing, medical imaging, and enterprise AI agents
The antibody was designed and developed at Abzena’s Cambridge, UK,
First research project, supported by the Gates Foundation, focuses on developing non-hormonal contraceptives for women in low- and middle-income countries
Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
Investment to expand manufacturing and global medicine supply capacity
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
Subscribe To Our Newsletter & Stay Updated
